ArticleScientific reports2025
Elucidating the role of group A Streptococcus genomics and pharyngeal microbiota in acute paediatric pharyngitis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Role of Next-Generation Sequencing in Excluding the Nosocomial Origin of a Case of Legionnaires' Disease Integrating Environmental Surveillance and Clinical Diagnosis.Microorganisms · 2026Article
- The invasive GAS puzzle in Italy: genomic insights from a hospital cohort in a fragmented surveillance landscape.Frontiers in cellular and infection microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The post pandemic period has witnessed a notable increase in invasive Streptococcus pyogenes (GAS) infections across several countries. This surge has been partly attributed to the emergence of more virulent strains, and factors like the non-pharmaceutical interventions or the immunity debt. Despite its dual role as both a commensal and pathogen, our understanding of GAS carriage and the dynamics influencing the transition to invasive disease remains limited. In particular, the role of the pharyngeal microbiota in modulating GAS colonization and infection warrants further investigation. We performed a comprehensive analysis of a pediatric cohort in the post pandemic period collecting clinical data alongside diagnostic evaluations by using pharyngeal swabs and Rapid Antigen Detection Tests (RADTs) to differentiate GAS-positive from GAS-negative cases. Comparative genomic analyses were performed on clinical isolates to identify the prevalence of specific clones or virulence determinants. Additionally, the pharyngeal microbiota was characterized using 16 S rRNA targeted sequencing to assess differences in microbial community composition between the two groups. The overall composition of the pharyngeal microbiota appeared comparable between GAS-positive and GAS-negative children. Alpha diversity metrics (Observed Species, Shannon diversity and Pielou's Evenness) were not significantly different (p = 0.820, p = 0.280 and p = 0.240, respectively), while Bray-Curtis defined two distinct groups (PERMANOVA, p = 0.01, R² = 0.523). The relative abundance of S. pyogenes within the Streptococcus genus emerged as a key differentiator. Genomic analysis revealed a mosaic representation of GAS clones, with the emm12.0 that was the most represented type, suggesting genomic characteristics did not directly correlate with the upsurge of respiratory GAS infections in our cohort. Our study underscores the complexity of GAS pathogenesis, highlighting that the transition from colonization to infection (acute pharyngitis) remains largely elusive and pharyngeal microbiota may contribute to a multifaceted interplay between host immunity and S. pyogenes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.